Publications by authors named "Marco Springer"

Claim this Profile
I
IFN-γ/IL-2 Double-Color FluoroSpot Assay for Monitoring Human Primary T Cell Activation: Validation, Inter-Laboratory Comparison, and Recommendations for Clinical Studies.
Alexandra Mauthe, Edward Cedrone, Raquel Villar-Hernández, Elisa Rusch, Marco Springer

AAPS J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecule transfer into mammalian cells by single sub-nanosecond laser pulses.
Florian Hausladen, Petra Kruse, Felicia Hessenberger, Thomas Stegmayer, Yu-Ting Kao, Marco Springer

J Biophotonics· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.
Friedrich H Schmitz-Winnenthal, Nicolas Hohmann, Thomas Schmidt, Lilli Podola, Tobias Friedrich, Marco Springer

Oncoimmunology· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.
Friedrich H Schmitz-Winnenthal, Nicolas Hohmann, Andreas G Niethammer, Tobias Friedrich, Heinz Lubenau, Marco Springer

Oncoimmunology· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.
Andreas G Niethammer, Heinz Lubenau, Gerd Mikus, Philipp Knebel, Nicolas Hohmann, Marco Springer

BMC Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a mechanically stable support for the osteoinductive biomaterial COLLOSS E.
Anja Lode, Anne Bernhardt, Kathrin Kroonen, Marco Springer, Arne Briest

J Tissue Eng Regen Med· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repair of sheep long bone cortical defects filled with COLLOSS, COLLOSS E, OSSAPLAST, and fresh iliac crest autograft.
William E Huffer, James J Benedict, A S Turner, Arne Briest, Robert Rettenmaier, Marco Springer

J Biomed Mater Res B Appl Biomater· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectopic bone induction by equine bone protein extract.
Haisheng Li, Marco Springer, Xuenong Zou, Arne Briest, Cody Bünger

Adv Exp Med Biol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Instrumented anterior lumbar interbody fusion with equine bone protein extract.
Haisheng Li, Xuenong Zou, Marco Springer, Arne Briest, Martin Lind

Spine (Phila Pa 1976)· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of 3-isobutyl-1-methylxanthine and kojic acid on cocultures and skin equivalents composed of HaCaT cells and human melanocytes.
Marco Springer, Karin Engelhart, Hans Konrad Biesalski

Arch Dermatol Res· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis